US expanded indication for Merck & Co shingles vaccine
This article was originally published in Scrip
Executive Summary
The US FDA has widened the age range indicated for Merck & Co's shingles vaccine Zostavax (Zoster vaccine live) to adults aged 50 years or older, but it will be some time before this will lead to any real expansion of sales of the product.